Dr Mathis Heydtmann studied at Mainz and Düsseldorf University with electives in several European countries. He passed the German and US medical licensing exams before working in the liver unit in Berne, Switzerland, then in Manchester, and he did his Specialist Registrar training in Birmingham. He trained in all aspects of Hepatology at the Queen Elizabeth Hospital and the Liver Transplant Unit Birmingham
After his PhD research in Liver Immunology in Birmingham, Dr Heydtmann was a Clinical Lecturer of Birmingham University. He moved to Glasgow in 2007 where he completed his training and worked as a Consultant Hepatologist and Gastroenterologist at the Royal Alexandra Hospital in Paisley up to August 2021.
He now works part time in Dumfries and Galloway Royal Infirmary, which allows him to dedicate more time in his interests in public health and health inequalities. He is a strong advocate for patients the deprived and often underserved patients with liver disease. For example, in the beginning of the pandemic, he lobbied to get our sickest patients with liver disease onto the national shielding lists.
Having worked in liver units for 8 years of his training, Dr Heydtmann has developed an early interest in all areas of acute and chronic liver disease: viral, toxic, autoimmune and genetic liver disease including alcoholic liver disease, fatty liver, chronic hepatitis B and C, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), investigation of abnormal liver biochemistry, management of chronic liver failure, assessment of patients for liver transplant and following up liver transplant patients.
Dr Heydtmann is an advanced endoscopist, JAG-accredited colonoscopist. He is also specialist advisor to the Scottish Public Services Ombudsman and a specialty advisor to the Scottish Chief Medical Officer for liver.
Dr Heydtmann has good links with other specialists who might need to be
involved in patient's care including surgeons, dieticians and addiction
Workup for abnormal liver results
Management of all patients with chronic liver disease: alcohol related, metabolic liver disease (including MAFLD – Metabolic Syndrome Associated Liver Disease previously also called NASH or NAFLD), viral, genetic, toxic, autoimmune (where the immune system plays up and fights against cells in the liver).
Management of patients with advanced liver disease including patients with advanced cirrhosis, decompensation and who need assessment for liver transplant.
Dr Heydtmann has an interest in communication skills, he is an appraiser for revalidation by the GMC, and a tutor training advanced appraisers for Scotland. He is a trained Mediator (Scottish Mediation) and a trained Negotiator (Program on Negotiation at Harvard Law School) and he is a National Panellist for consultant appointments. Dr Heydtmann is actively involved in research on different aspects of liver disease including alcohol related liver disease, fatty liver disease and the link between liver disease and deprivation.
Dr Heydtmann enjoys spending time with his wife and his amazing two daughters – in particular traveling and watching them perform at school plays, cycling and skiing.
Treatments and tests offered by Dr Mathis Heydtmann at Nuffield Health
- Blood test
- Flexible sigmoidoscopy
- Liver biopsy
- Diagnostic endoscopy
- Liver function tests
Dr Heydtmann obtained an MD in molecular genetics from Düsseldorf University (1996) and was awarded a The Wellcome Trust Clinical Training Fellowship to study for a PhD in liver immunology at Birmingham University, which he successfully completed in 2005. As part of his PhD he undertook a research attachment at Harvard University, Boston.
He maintains a keen interest in academic medicine by advancing medical knowledge in his field and by teaching. His research work includes a CSO-funded project on alcoholic liver disease epidemiology, health economics, genetics of liver disease, and management of chronic liver disease and he is currently involved in trials on fatty liver (NAFLD). He has published widely in hepatology in high impact factor journals.
- British Association for the Study of the Liver (BASL)
- European Association on the Study of the Liver (EASL)
- American Association on the Study of Liver Disease (AASLD)
- Scottish Society of Gastroenterology (SSG) Council Member (Secretary 2018 – 2020)
- British Society of Gastroenterology (BSG): Member of IQILS (Improving Quality in Liver Disease) Standard development group
- Scottish Society of Physicians (SSP)
- Royal College of Physicians and Surgeons of Glasgow (RCPSG): Fellow
- Royal College of Physicians (London)
- Royal College of Physicians of Edinburgh
Other posts held
- Consultant Hepatologist, Dumfries & Galloway Royal Infirmary
Dr Mathis Heydtmann does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Mathis Heydtmann does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Mathis Heydtmann does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.